相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The degradation of EZH2 mediated by lncRNA ANCR attenuated the invasion and metastasis of breast cancer
Zhongwei Li et al.
CELL DEATH AND DIFFERENTIATION (2017)
Over-expressed long noncoding RNA HOXA11-AS promotes cell cycle progression and metastasis in gastric cancer
Zhili Liu et al.
MOLECULAR CANCER (2017)
Long Noncoding RNA LINC00673 Is Activated by SP1 and Exerts Oncogenic Properties by Interacting with LSD1 and F7H2 in Gastric Cancer
Mingde Huang et al.
MOLECULAR THERAPY (2017)
Integrated genomic characterization of oesophageal carcinoma
Jihun Kim et al.
NATURE (2017)
MicroRNA-30d inhibits the migration and invasion of human esophageal squamous cell carcinoma cells via the post -transcriptional regulation of enhancer of zeste homolog 2
Rui Xie et al.
ONCOLOGY REPORTS (2017)
LncRNA-ANCR down-regulation suppresses invasion and migration of colorectal cancer cells by regulating EZH2 expression
Zhao-Yang Yang et al.
CANCER BIOMARKERS (2017)
A covalently bound inhibitor triggers EZH2 degradation through CHIP-mediated ubiquitination
Xu Wang et al.
EMBO JOURNAL (2017)
miR-98 inhibits hepatocellular carcinoma cell proliferation via targeting EZH2 and suppressing Wnt/β-catenin signaling pathway
Jun-Jie Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
SAM/SAH Analogs as Versatile Tools for SAM-Dependent Methyltransferases
Jing Zhang et al.
ACS CHEMICAL BIOLOGY (2016)
The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells
Christian Mayr et al.
ONCOTARGET (2016)
EZH2 in normal hematopoiesis and hematological malignancies
Laurie Herviou et al.
ONCOTARGET (2016)
Long noncoding RNA H19 regulates EZH2 expression by interacting with miR-630 and promotes cell invasion in nasopharyngeal carcinoma
Xudong Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
MALAT1 long non-coding RNA in cancer
Rei Yoshimoto et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2016)
LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1
Ming Sun et al.
CANCER RESEARCH (2016)
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
Michele Ceccarelli et al.
CELL (2016)
miR-340 impedes the progression of laryngeal squamous cell carcinoma by targeting EZH2
Wenfa Yu et al.
GENE (2016)
Identification of (R)-N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (CPI-1205), a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, Suitable for Phase I Clinical Trials for B-Cell Lymphomas
Rishi G. Vaswani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2
Xin Wang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Divergent clonal selection dominates medulloblastoma at recurrence
A. Sorana Morrissy et al.
NATURE (2016)
Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas
Joshua D. Campbell et al.
NATURE GENETICS (2016)
Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer
Hikmat A. Al-Ahmadie et al.
NATURE GENETICS (2016)
HIFI-α activation underlies a functional switch in the paradoxical role of Ezh2/PRC2 in breast cancer
Sylvia Mahara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Long non-coding RNA IRAIN suppresses apoptosis and promotes proliferation by binding to LSD1 and EZH2 in pancreatic cancer
Yifan Lian et al.
TUMOR BIOLOGY (2016)
MicroRNA-298 inhibits malignant phenotypes of epithelial ovarian cancer by regulating the expression of EZH2
Fenmei Zhou et al.
ONCOLOGY LETTERS (2016)
Long noncoding RNA MALAT1 promotes malignant development of esophageal squamous cell carcinoma by targeting β-catenin via Ezh2
Wei Wang et al.
ONCOTARGET (2016)
MALAT1 long ncRNA promotes gastric cancer metastasis by suppressing PCDH10
Ying Qi et al.
ONCOTARGET (2016)
Deletion of the Polycomb-Group Protein EZH2 Leads to Compromised Self-Renewal and Differentiation Defects in Human Embryonic Stem Cells
Adam Collinson et al.
CELL REPORTS (2016)
Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation
Marie-Claude Gingras et al.
CELL REPORTS (2016)
Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma
Marios Giannakis et al.
CELL REPORTS (2016)
Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis
Celine Lefebvre et al.
PLOS MEDICINE (2016)
Polycomb repressive complex's evolutionary conserved function: the role of EZH2 status and cellular background
Koraljka Gall Troselj et al.
CLINICAL EPIGENETICS (2016)
Downregulation of Enhancer of Zeste Homolog 2 (EZH2) Is Essential for the Induction of Autophagy and Apoptosis in Colorectal Cancer Cells
Yizhou Yao et al.
GENES (2016)
Long Intergenic Noncoding RNA 00511 Acts as an Oncogene in Non-small-cell Lung Cancer by Binding to EZH2 and Suppressing p57
Cheng-Cao Sun et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2016)
Long non-coding RNA LINC00628 functions as a gastric cancer suppressor via long-range modulating the expression of cell cycle related genes
Zi-Zhen Zhang et al.
SCIENTIFIC REPORTS (2016)
siRNA Silencing EZH2 Reverses Cisplatin-resistance of Human Non-small Cell Lung and Gastric Cancer Cells
Wen Zhou et al.
Asian Pacific Journal of Cancer Prevention (2015)
Malat1 as an evolutionarily conserved lncRNA, plays a positive role in regulating proliferation and maintaining undifferentiated status of early-stage hematopoietic cells
Xian-Yong Ma et al.
BMC GENOMICS (2015)
Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205
Hiroshi Hirata et al.
CANCER RESEARCH (2015)
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
Giovanni Ciriello et al.
CELL (2015)
Genomic Analysis of Metastatic Cutaneous Squamous Cell Carcinoma
Yvonne Y. Li et al.
CLINICAL CANCER RESEARCH (2015)
Genomic Predictors of Survival in Patients with High-grade Urothelial Carcinoma of the Bladder
Philip H. Kim et al.
EUROPEAN UROLOGY (2015)
Phosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma
Jiro Kikuchi et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Comprehensive genomic profiles of small cell lung cancer
Julie George et al.
NATURE (2015)
Comprehensive genomic characterization of head and neck squamous cell carcinomas
Michael S. Lawrence et al.
NATURE (2015)
Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway
A. Hunter Shain et al.
NATURE GENETICS (2015)
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
Kornelius Schulze et al.
NATURE GENETICS (2015)
EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo Activity
John E. Campbell et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors
Daniel Zingg et al.
NATURE COMMUNICATIONS (2015)
EZH2 is crucial for both differentiation of regulatory T cells and T effector cell expansion
Xiang-Ping Yang et al.
SCIENTIFIC REPORTS (2015)
Prolonged Ezh2 Depletion in Glioblastoma Causes a Robust Switch in Cell Fate Resulting in Tumor Progression
Nienke A. de Vries et al.
CELL REPORTS (2015)
EZH2 promotes tumor progression by increasing VEGF expression in clear cell renal cell carcinoma
Z. Q. Xu et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2015)
The role of polycomb repressive complexes in biliary tract cancer
Christian Mayr et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
EZH2 Inhibitor Efficacy in Non-Hodgkin's Lymphoma Does Not Require Suppression of H3K27 Monomethylation
William D. Bradley et al.
CHEMISTRY & BIOLOGY (2014)
Role of EZH2 in oral squamous cell carcinoma carcinogenesis
Lingbo Zhao et al.
GENE (2014)
Genomic Portrait of Resectable Hepatocellular Carcinomas: Implications of RB1 and FGF19 Aberrations for Patient Stratification
Sung-Min Ahn et al.
HEPATOLOGY (2014)
microRNA-124 inhibits proliferation and induces apoptosis by directly repressing EZH2 in gastric cancer
Liming Xie et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma
Sarah K. Knutson et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
Comprehensive molecular profiling of lung adenocarcinoma
Eric A. Collisson et al.
NATURE (2014)
Identification of genomic alterations in oesophageal squamous cell cancer
Yongmei Song et al.
NATURE (2014)
Comprehensive molecular characterization of urothelial bladder carcinoma
John N. Weinstein et al.
NATURE (2014)
Downregulation of microRNA-26a is associated with metastatic potential and the poor prognosis of osteosarcoma patients
Qi-Chun Song et al.
ONCOLOGY REPORTS (2014)
MicroRNA-101 inhibits the metastasis of osteosarcoma cells by downregulation of EZH2 expression
Kailiang Zhang et al.
ONCOLOGY REPORTS (2014)
Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma
Brett E. Johnson et al.
SCIENCE (2014)
MicroRNA-124 inhibits cellular proliferation and invasion by targeting Ets-1 in breast cancer
Wentao Li et al.
TUMOR BIOLOGY (2014)
Genomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genes
Sian Jones et al.
NATURE COMMUNICATIONS (2014)
The Genomic Landscape of Pediatric Ewing Sarcoma
Brian D. Crompton et al.
CANCER DISCOVERY (2014)
Somatic ERCC2 Mutations Correlate with Cisplatin Sensitivity in Muscle-Invasive Urothelial Carcinoma
Eliezer M. Van Allen et al.
CANCER DISCOVERY (2014)
Genomic Landscape of Ewing Sarcoma Defines an Aggressive Subtype with Co-Association of STAG2 and TP53 Mutations
Franck Tirode et al.
CANCER DISCOVERY (2014)
EZH2: novel therapeutic target for human cancer
Long-Yuan Li
BIOMEDICINE-TAIWAN (2014)
An Orally Bioavailable Chemical Probe of the Lysine Methyltransferases EZH2 and EZH1
Kyle D. Konze et al.
ACS CHEMICAL BIOLOGY (2013)
Enhancer of Zeste Homolog 2 (EZH2) Promotes Progression of Cholangiocarcinoma Cells by Regulating Cell Cycle and Apoptosis
Shigeki Nakagawa et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Phosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells
Eunhee Kim et al.
CANCER CELL (2013)
Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression
Ming Luo et al.
CANCER LETTERS (2013)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Three-dimensional culture sensitizes epithelial ovarian cancer cells to EZH2 methyltransferase inhibition
Michael D. Amatangelo et al.
CELL CYCLE (2013)
MiR-138 Inhibits Tumor Growth Through Repression of EZH2 in Non-Small Cell Lung Cancer
Huijun Zhang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2013)
Non-coding RNAs and EZH2 interactions in cancer: Long and short tales from the transcriptome
Leonidas Benetatos et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
EZH2 Promotes E2F-Driven SCLC Tumorigenesis through Modulation of Apoptosis and Cell-Cycle Regulation
Roland Hubaux et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
PAF and EZH2 Induce Wnt/β-Catenin Signaling Hyperactivation
Hae-Yun Jung et al.
MOLECULAR CELL (2013)
Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton et al.
NATURE (2013)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity
Austin M. Dulak et al.
NATURE GENETICS (2013)
The genomic landscape of hypodiploid acute lymphoblastic leukemia
Linda Holmfeldt et al.
NATURE GENETICS (2013)
Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer
Sakari Vanharanta et al.
NATURE MEDICINE (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
MiR-138 Induces Renal Carcinoma Cell Senescence by Targeting EZH2 and Is Downregulated in Human Clear Cell Renal Cell Carcinoma
Jiaqian Liang et al.
ONCOLOGY RESEARCH (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis
Francesco Crea et al.
CANCER AND METASTASIS REVIEWS (2012)
CellMiner: A Web-Based Suite of Genomic and Pharmacologic Tools to Explore Transcript and Drug Patterns in the NCI-60 Cell Line Set
William C. Reinhold et al.
CANCER RESEARCH (2012)
A Landscape of Driver Mutations in Melanoma
Eran Hodis et al.
CELL (2012)
Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Marcin Imielinski et al.
CELL (2012)
PRC2 directly methylates GATA4 and represses its transcriptional activity
Aibin He et al.
GENES & DEVELOPMENT (2012)
EZH2 couples pancreatic regeneration to neoplastic progression
Jon Mallen-St Clair et al.
GENES & DEVELOPMENT (2012)
The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2
Fang Zheng et al.
GUT (2012)
MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma
Sheng-Dong Huang et al.
MOLECULAR CANCER (2012)
EZH2 Generates a Methyl Degron that Is Recognized by the DCAF1/DDB1/CUL4 E3 Ubiquitin Ligase Complex
Ji Min Lee et al.
MOLECULAR CELL (2012)
Recurrent R-spondin fusions in colon cancer
Somasekar Seshagiri et al.
NATURE (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Comprehensive genomic characterization of squamous cell lung cancers
Peter S. Hammerman et al.
NATURE (2012)
A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells
Sarah K. Knutson et al.
NATURE CHEMICAL BIOLOGY (2012)
Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer
Charles M. Rudin et al.
NATURE GENETICS (2012)
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
Michael Krauthammer et al.
NATURE GENETICS (2012)
Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia
Panagiotis Ntziachristos et al.
NATURE MEDICINE (2012)
Hypoxia Induced Aggressiveness of Prostate Cancer Cells Is Linked with Deregulated Expression of VEGF, IL-6 and miRNAs That Are Attenuated by CDF
Bin Bao et al.
PLOS ONE (2012)
Hypoxia-Induced Aggressiveness of Pancreatic Cancer Cells Is Due to Increased Expression of VEGF, IL-6 and miR-21, Which Can Be Attenuated by CDF Treatment
Bin Bao et al.
PLOS ONE (2012)
Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation
Wei Qi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing
Jens G. Lohr et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent
Kexin Xu et al.
SCIENCE (2012)
Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2
Sharad K. Verma et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cells
Xiaomin Dang et al.
CANCER GENETICS (2012)
MicroRNA-138 suppresses epithelial-mesenchymal transition in squamous cell carcinoma cell lines
Xiqiang Liu et al.
BIOCHEMICAL JOURNAL (2011)
Dependency on the polycomb gene Ezh2 distinguishes fetal from adult hematopoietic stem cells
Makiko Mochizuki-Kashio et al.
BLOOD (2011)
Context-Specific Regulation of NF-κB Target Gene Expression by EZH2 in Breast Cancers
Shuet Theng Lee et al.
MOLECULAR CELL (2011)
Frequent pathway mutations of splicing machinery in myelodysplasia
Kenichi Yoshida et al.
NATURE (2011)
Predicting the functional impact of protein mutations: application to cancer genomics
Boris Reva et al.
NUCLEIC ACIDS RESEARCH (2011)
The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Nicolas Stransky et al.
SCIENCE (2011)
MicroRNAs: Synthesis, mechanism, function, and recent clinical trials
Fazli Wahid et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
The H19 locus: Role of an imprinted non-coding RNA in growth and development
Anne Gabory et al.
BIOESSAYS (2010)
MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion
Hui-Ju Wang et al.
EUROPEAN JOURNAL OF CANCER (2010)
The Nuclear-Retained Noncoding RNA MALAT1 Regulates Alternative Splicing by Modulating SR Splicing Factor Phosphorylation
Vidisha Tripathi et al.
MOLECULAR CELL (2010)
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
Rajnish A. Gupta et al.
NATURE (2010)
miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis
Michiel Smits et al.
ONCOTARGET (2010)
Recruitment of Polycomb group complexes and their role in the dynamic regulation of cell fate choice
Bernd Schuettengruber et al.
DEVELOPMENT (2009)
Long non-coding RNAs: insights into functions
Tim R. Mercer et al.
NATURE REVIEWS GENETICS (2009)
Mechanisms of Polycomb gene silencing: knowns and unknowns
Jeffrey A. Simon et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Regulation of Pancreatic Tumor Cell Proliferation and Chemoresistance by the Histone Methyltransferase Enhancer of Zeste Homologue 2
Andrei V. Ougolkov et al.
CLINICAL CANCER RESEARCH (2008)
Polycomb group protein-associated chromatin is reproduced in post-mitotic G1 phase and is required for S phase progression
Takahiro Aoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Dominant alleles identify SET domain residues required for histone methyltransferase of polycomb repressive complex 2
Preeti Joshi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Ezh1 and Ezh2 Maintain Repressive Chromatin through Different Mechanisms
Raphael Margueron et al.
MOLECULAR CELL (2008)
Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer
Sooryanarayana Varambally et al.
SCIENCE (2008)
Polycomb Group proteins: an evolutionary perspective
Sarah J. Whitcomb et al.
TRENDS IN GENETICS (2007)
Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells
Bin Shi et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells
Adrian P. Bracken et al.
GENES & DEVELOPMENT (2007)
The polycomb group protein EZH2 is required for mammalian circadian clock function
Jean-Pierre Etchegaray et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Control of developmental regulator's by polycomb in human embryonic stem cells
TI Lee et al.
CELL (2006)
EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast
IM Bachmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Polycomb group protein Ezh2 controls actin polymerization and cell signaling
I Su et al.
CELL (2005)
The SANT domain: a unique histone-tail-binding module?
LA Boyer et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement
IH Su et al.
NATURE IMMUNOLOGY (2003)
The development and clinical use of trastuzumab (Herceptin)
M Harries et al.
ENDOCRINE-RELATED CANCER (2002)
分享论文
